Maxwell Towe

University of California, Irvine Medical Center

Papers

Total Citations

H-Index

About

Maxwell Towe is a clinical researcher whose work focuses on the intersection of endocrinology and urology, particularly the role of testosterone in prostate cancer (PCa) management. His most cited study, “Evidence for the integration of total and free testosterone levels in the management of prostate cancer” (2021), is a landmark prospective cohort analysis that systematically evaluated both total and calculated free testosterone levels in PCa patients. This work demonstrated how these hormonal biomarkers correlate with disease aggressiveness and recurrence outcomes, providing a more nuanced framework for risk stratification beyond traditional PSA-based models. By advocating for the routine integration of free testosterone measurements into clinical practice, Towe’s research challenges conventional dogma and offers a path toward personalized treatment strategies. With 5 citations, this study has already informed subsequent investigations into hormonal influences on prostate cancer progression. Towe’s contributions are particularly notable for bridging a critical gap in understanding how androgen dynamics affect tumor biology, making his work essential reading for clinicians and researchers exploring the complex interplay between endocrine function and oncological outcomes.